INTRODUCTION
Although the aetiology of Crohn's disease remains an enigma, it is generally thought that the Crohn's disease syndrome results, in part or in whole, from an abnormal or dysregulated immune response to specific and/or commensal bacteria arising from the intestinal lumen in susceptible individuals [1] . As a result, a great deal of attention has been devoted to the examination of the composition and function of the intestinal microbial populations known as the microbiota [2] . Although the bacterial populations found in downstream faecal material and adherent to mucosal surfaces have been found to be dysbiotic (microbial imbalance) in Crohn's disease patients as compared to normal controls [3] , the data accumulated to date have not elucidated the causative factors or aetiological mechanisms of the disease. It remains unclear whether the dysbiosis is related to the cause of the disease or simply an effect of the disease unrelated to initial causality.
We previously reported the ability to compare the microbiota deep within the submucosal tissues to those present on the superjacent mucosal surfaces [4] and the ability to differentiate invasive organisms from those adherent to superficial mucosal surfaces. The evidence suggested the existence of a distinct submucosal intestinal microbiota and ecosystem that was not well reflected in the mucosa and/or downstream faecal material [4, 5] . These data suggested that the primary site of bacterial translocation across the mucosal barrier occurs at the margin between diseased and normal tissue, the advancing disease margin [5] . The heterogeneity of the bacterial populations penetrating the mucosal barrier and colonizing the submucosal intestinal tissues also suggested that the bacterial translocation is secondary to a primary event leading to a breakdown of the mucosal barrier.
Since the recurrence of Crohn's disease following surgical resection most commonly occurs at the resection margin as new inflammation [6, 7] , we hypothesized that anatomical sites proximal to the resection margin would provide an insight into the bacterial populations associated with disease less influenced by the mucosal dysbiosis and anatomical changes associated with inflammation. We also hypothesized that the resection margin, being a site of new inflammation in advanced disease, could be used as a model of new onset and/or recurrence, even in cases of advanced disease.
The ultimate goal of Crohn's disease research is to find the cause and cure. Comparing the mucosal and/or faecal microbiota in Crohn's disease patients to those of normal controls provides information on dysbiosis. However, dysbiosis is not unique to Crohn's disease but occurs in a host of other intestinal diseases and conditions. Comparing the microbiota in Crohn's disease patients to those of normal controls does not distinguish features that are unique to Crohn's disease or determine whether the dysbiosis is a consequence of the disease rather being than related to aetiology. Thus, we chose to compare the dysbiosis in Crohn's disease to the dysbiosis in other intestinal disorders in order to determine what was unique in Crohn's disease and not simply a common feature of dysbiosis. In addition, defining exclusive features of the Crohn's disease-associated dysbiosis could identify unique biomarkers not found in other dysbiotic disease states.
We report herein the comparison of the submucosal microbiota at the resection margin (anastomotic site) in Crohn's disease, considered at the time of surgery to have no signs of inflammation, to those at the resection margin in other intestinal diseases with dysbiosis. We also reanalysed data from previous studies on the microbiota at the disease centre [4] and advancing disease margin [5] within the context of the resection margin and progression from normal to diseased tissues. Our findings suggest the existence and exclusion of certain bacterial families throughout the disease spectrum and that the bacterial population at the resection margin continues to display evidence of bacterial translocation, suggesting mucosal breakdown/disruption.
METHODS

Patient populations
This study was approved by the institutional review boards (IRBs) of the University of Louisville and Texas Tech University Health Sciences Center, and the Institutional Review Board of Billings (St Vincent Healthcare and Montana State University-Billings). Informed consent was obtained from all patients in writing on IRB-approved consent forms prior to the collection of any specimens and/or data. Patients with ileal Crohn's disease and controls (non-IBD populations) scheduled for surgical resection were recruited from the University of Louisville, Kentucky, and Texas Tech University Health Sciences Center, El Paso, and affiliated Hospitals. Detailed clinical histories, including sex, ethnicity, date of disease onset, past and current medications, pro-and prebiotics, prior surgeries, family history, secondary disease sites, concurrent disease, use of pre-surgical bowel cleansers and other clinical parameters, were collected pre-operatively at the time of informed consent. From each patient, a fullthickness section of the resection margin (anastomotic site) of at least 127 mm 2 (½ inch   2 ) was collected at the time of surgery by a colorectal surgeon [8] with extensive experience in inflammatory bowel disease surgery. The tissue samples were frozen immediately after collection.
Previously reported data obtained from this patient population [4, 5] were reanalysed for the purpose of comparison to the data obtained at the anastomotic site reported herein. For inclusion, tissues and DNA needed to be available from the mucosa and submucosa from the disease centre (DM and DS, respectively), the mucosa and submucosa from the disease margin (MM and MS, respectively), and the normal mucosa and submucosa from the resection margin (NM and NS, respectively). The tissues from each patient were collected during a single surgical procedure.
Tissue processing and DNA extraction The methods employed for the processing of tissues, separation of mucosal and submucosal tissues and extraction of DNA have been described previously in detail [4] . Briefly, equally weighted sections of intestinal tissue were cut from the resected sample and weighed. Under magnification, the mucosal layer was manually excised from the tissue and transferred to a microcentrifuge containing DL-dithiothreitol (DTT) and mixed on a pulsating vortex mixer. The supernatant was centrifuged and DNA was extracted from the sediment as mucosal DNA. The remaining tissue consisting of the submucosa, muscularis and serosa, hereafter referred to simply as the 'submucosa', was washed to remove any surface adherent material and treated with DTT to dissolve any remaining mucus. DNA was extracted from the pelleted mucosal digest and solid submucosal tissue by employing a modification of previously described methods [4, 5] , with the MoBio PowerMax Soil DNA Isolation kit (MO BIO Laboratories, Inc., Carlsbad, CA, USA) playing a partial role. The tissues were placed in a high-energy cell disrupter (Mini-Beadbeater, Biospec Products, Inc., Bartlesville, OK, USA) containing 100 µm molecular biology-grade zirconium beads, 2.8 mm stainless steel grinding balls (only added to solid tissue vials) (OPS Diagnostics, Lebanon, NJ, USA), proteinase K (recombinant PCR grade), MoBio Power Bead Solution and MoBio Solution C1, and violently agitated at maximum speed. Following bead-beating, the contents of the vials were transferred to sterile 50 ml conical tubes and processed per the manufacturer's instructions for the MoBio PowerMax Soil DNA Isolation kit. The amount of DNA in ng per µl was determined in a NanoDrop spectrophotometer at 260 nm. DNA was extracted from each tissue samples from each patient at the same time using identical methods and reagent lot numbers. All DNA samples were normalized to a concentration of 50 ng DNA per µl and equimolar amounts of DNA were sequenced.
16S rRNA gene sequencing on the Illumina MiSeq platform The 16S universal eubacterial primers 27Fmod and 519Rmod, targeting the V1-V3 region, were utilized to evaluate the microbial ecology of samples on the Illumina MiSeq platform with methods based upon the bTEFAP process as previously described [4] . Briefly, a single-step 30 cycle PCR using the HotStarTaq Plus Master Mix kit (Qiagen, Valencia, CA, USA) was used under the following conditions: 94 C for 3 min, followed by 28 cycles of 94 C for 30 s; 53 C for 40 s and 72 C for 1 min; after which a final elongation step at 72 C for 5 min was performed. Multiple samples were pooled together in equal proportions based on their molecular weight and DNA concentrations. Pooled samples were purified using calibrated Ampure XP beads. The pooled and purified PCR products were used to prepare DNA libraries according to the Illumina TruSeq DNA library preparation protocol.
Sequencing was performed using the Illumina MiSeq sequencing platform following the manufacturer's guidelines. The Q25 sequence data derived from the sequencing process were processed using a standardized analysis pipeline [4] . In brief, the sequences were joined and depleted of barcodes, and sequences <150 bp and sequences with ambiguous base calls were removed. The sequences were denoised, operational taxonomic units (OTUs) were generated and chimeras were removed using UCHIME [9] . The OTUs were defined after the removal of singleton sequences, clustering at 3 % divergence (97 % similarity) using UCLUST in standard default [10, 11] . The final OTUs were taxonomically classified using BLASTN against a curated database derived from the GreenGenes version 13.5 (http:// greengenes.secondgenome.com/), RDPII (http://rdp.cme. msu.edu) and NCBI (www.ncbi.nlm.nih.gov) databases (including non-bacterial sequences), and compiled into each taxonomic level by both 'counts' (actual number of sequences) and 'percentage' (relative proportion of sequences within each sample) files. Samples that generated fewer than 10 000 fasta counts were excluded from the study as well as the reciprocal sample, e.g. if the submucosal sample generated fewer than 10 000 counts, both the submucosal and mucosal data were excluded. Rarefying was not performed [12] . Bacterial OTUs were assigned a taxonomic classification based on previously described taxonomic designations [4] .
DNA and bacterial quantitation
In an attempt to compensate for the bias created by erroneously assuming a 1 : 1 ratio of rRNA genes across the entire bacterial community, the actual number of sequences from the raw fasta count files was divided by the average number of rrn operons (rRNA copies) at each taxonomic level based on the Ribosomal RNA Database (rrnDB) [5, 13] .
Monitoring contamination
The DNA extraction and sequencing kits, and all the reagents used in the processing of tissues, were monitored for inherent bacterial DNA contamination as previously described [14] . Briefly, to monitor contamination from the reagents used during the DNA extraction procedure, irradiated molecular biology grade (irMBG) water was processed through all lots of any used DNA extraction kit and the product sequenced as above concurrent with tissue DNA samples. If a single DNA sample was suspected to be contaminated or otherwise influenced by exogenous contamination as previously defined [14] , the patient and all samples were excluded from the study.
Statistical analysis
Statistical analysis was performed using a variety of computer packages, including XLstat, NCSS 2007, R (http://www.r-project.org/) and NCSS 2010 [5] . The statistical analysis of alpha and beta diversity was performed from taxonomic classifications and phylogenetic-based methods (UniFrac), not dependent on OTU assignments, as described previously using the Qiime pipeline (www.qiime.org) with standard scripts and default settings for taxa assignments (genus and higher), diversity estimates (OTUs, Chao1 index, phylogenetic distance index, Shannon index and Simpson index) and phylogenybased analyses using UniFrac. Because most datasets do not meet the assumptions of normal distribution, the differences in the proportions of bacterial taxa (defined as percentage of total sequences) between mucosal and submucosal groups were determined using the nonparametric Kruskal-Wallis test. For comparisons involving two or more groups, the Kruskal-Wallis test and the Mann-Whitney post-test were applied for non-parametric data, and ANOVA with TukeyKramer post hoc analysis was applied for parametric data. Comparisons between two groups was performed using the Mann-Whitney post-test and/or the paired Student t-test. Significance for any analysis was defined as P<0.05, corrected for multiple testing using ANOVA with Tukey's honestly significant difference (HSD) post hoc analysis.
RESULTS
Patient populations
Tissues from the resection margin at the terminal ileum were obtained from 20 patients with Crohn's disease and 16 non-IBD controls (Table S1 , available in the online version of this article). Of the patients with Crohn's disease, 13 were female and 7 were male, and they had a mean age of 41 years (range, 24-66 years). Nineteen patients were Caucasian and one was African-American. Only three patients had received antibiotics, while seven had received anti-TNF treatment (either imfliximab or adalimumab) within 6 months of surgery. The disease duration ranged from 1 to 34 years (mean 17 years) and 11 patients (65 %) had a previous small bowel resection. Five patients had a relative with Crohn's disease.
The non-IBD control population consisted of 12 female and 4 male patients undergoing ileocolic resection for a variety of reasons unrelated to inflammatory bowel disease. An effort was made to obtain a diverse control population. Eleven of the control patients were Caucasian, four were Hispanic and one was African-American. The mean age of this population was 58 years (range 32-88) and four patients had received antibiotics within 6 months prior to surgery. Further details and clinical histories for the Crohn's disease and control populations are provided in Table S1 .
There was a wide range and variety of treatments within both the Crohn's disease and non-IBD control groups. There was a significant difference (P=0.004) between the age of the Crohn's disease (average 41 years) and the non-IBD controls (average 57 years) groups, as well as the use of steroids (P=0.03) and anti-tumour necrosis a (TNF) antibody therapy (P=0.03) within the last 6 months. There was no statistically significant difference in the use of antibiotics, steroids, biologics, or antibiotics at the time of surgery. There was also no statistically significant correlation between the detected microbiota and any clinical parameter, including treatment and chemotherapeutic agents.
Overall sequencing A total of 72 DNA samples were processed and examined (superjacent mucosa and underlying subjacent submucosa from each of the 36 patients). From these samples, 4 100 092 sequences were generated, of which 4 048 606 (98.7 %) aligned to the kingdom Bacteria. The number of sequences generated per sample averaged 86 337. These sequences clustered into 7321 unique sequences or OTUs at 3 % divergence (97 % homology), allowing for the identification of 15 bacterial phyla, 12 classes, 59 orders, 122 families, 305 genera and 798 tentative species. The average number of bacterial species identified per patient was 128, with an average of 72 species being detected in more than 50 % of the study population. The mucosal tissues generally produced a greater number of valid rRNA gene sequences as compared to the subjacent submucosa (117 725 vs 54 088 respectively; P=0.03) and contained a larger number of detected bacterial genera (P=0.04). Although correcting bacterial abundance based on rRNA copy number greatly affected the community profile of bacteria, it did not affect statistical significance.
The mucosal microbiota at the resection margin (anastomotic site) In an attempt to understand what was unique in the microbiota of Crohn's disease patients, as opposed to what was different from normal controls in other studies, we compared the microbiota of normal-appearing tissues at the resection margin in advanced Crohn's disease to the microbiota at the resection margin in a variety of other non-IBD intestinal conditions known to also be dysbiotic (controls). This comparison suggests that several of the features of the Crohn's disease-associated microbiota may not be unique to Crohn's disease (Fig. 1a) . Specifically, at the phylum level, although Proteobacteria were elevated in Crohn's disease as compared to the levels reported for normal mucosal biopsy and faecal controls [15] , these bacteria were reduced in Crohn's disease as compared to other diseases (12 % vs 31 % respectively; P=0.016). In general, as compared to the mucosa of other intestinal disease states, most bacterial groups were reduced in Crohn's disease, including bacteria represented within the orders Burkholderiales (P=0.012), Pseudomonadales (P=0.015), Rhizobiales (P=0.044) and Selenomonadales, which was completely absent in Crohn's disease (P=<0.001) (Fig. 1b) . The only bacteria that were increased within the mucosa of Crohn's disease were bacteria of the family Coriobacteriaceae (with respective increases in the order and class), which was reflected predominately in increased bacteria of the genus Collinsella. Organisms of the order Enterobacteriales were also increased in Crohn's disease, but only approached statistical significance at the order or family Enterobacteriaceae levels (P=0.058).
There was no significant difference in the overall bacterial diversity (Shannon's or Simpson's indices) of the mucosal microbiota between the resection margin in Crohn's disease and the non-IBD controls at the genera or species level. Although the diversity did not differ between the two groups, there was a significant increase in richness (P=<0.001) within the Crohn's disease group, with 97 genera as opposed to 61 in the non-IBD group. This increased richness was due to genera within the phylum Proteobacteria (26 in Crohn's disease and 17 in non-IBD, P=0.003) and genera within the phylum Actinobacteria (13 in Crohn's disease and 7 in non-IBD, P=<0.001). There were no richness differences in genera of the phyla Firmicutes or Bacteroidetes, and there was no significant difference in Faecalibacterium prausnitzii between Crohn's disease and the controls.
These data suggest that the increased bacteria of the phylum Proteobacteria and the reduced abundance of Faecalibacterium prausnitzii in Crohn's disease, as well as the reduced biodiversity of the phylum Firmicutes, may be common features of dysbiosis and not unique to Crohn's disease.
The submucosal microbiota at the resection margin To determine the bacteria present deep within submucosal tissues and those most likely to have penetrated the mucosal barrier, we compared the subjacent submucosal to the superjacent mucosa of the diseased intestinal tissues of patients with Crohn's disease and non-IBD controls. There was no significant difference in the relative bacterial abundance between the mucosa and the subjacent submucosa within the non-IBD control population at any bacterial taxonomic level. This lack of any significant difference suggests that bacterial translocation across the mucosal barrier Fig. 1 . Differences in the mucosal microbiota at the resection margin in Crohn's disease as compared to non-IBD controls. (a). Bacterial taxon distribution of the predominant phyla within mucosal tissues of patients with Crohn's disease and non-IBD controls. Only Proteobacteria were significantly different (P=0.03), representing 31 % relative abundance in non-IBD controls and 12 % in Crohn's disease, suggesting that increased Proteobacteria is a feature common to intestinal dysbiosis. (b). Bacterial taxon distribution and relative percentage of the bacterial population of the mucosa. At the taxonomic level of order, the relative abundance of several bacterial taxa was reduced in Crohn's disease, with increases observed only with bacteria of the order Coriobacteriaceae. Bacteria of the order Selenomonadales were not detected in Crohn's disease. Although bacteria of the order Enterobacteriales and family Enterobacteriaceae were increased as compared to non-IBD controls, the differences were not statistically significant (P>0.05). Numbers above bar represent P values.
may not be a prominent feature within the non-IBD control group. In Crohn's disease, unlike the situation previously described for the submucosa of the disease centre [4] and advancing disease margin [5] , there was little evidence suggesting deep tissue penetration and translocation of bacteria at the resection margin. The only significant difference in bacterial abundance between the subjacent submucosa and superjacent mucosa concerned organisms of the families Comamonadaceae (P=0.039) and Xanthomonadaceae (P=0.049), as reflected in the genus Stenotrophomonas (P=0.044). These bacteria were also found to have increased abundance within the submucosa at the disease margin [5] .
Although there was minimal submucosal microbiota at the resection margin as compared to other disease sites [4, 5] , comparing the submucosa of the resection margin to the submucosa of non-IBD controls revealed a bacterium belonging to an unclassified family of the order Desulfovibrionales in approximately 30 % of Crohn's disease patients (absent in non-IBD controls). In addition, a bacterium belonging to an unclassified family of the order Selenomonadales was detected in 11 of 17 (64.7 %) controls, but was absent in all 20 Crohn's disease patients (Fig. 2) . There organisms of the order Desulfovibrionales were present in relatively low abundance (0.041 %; range, 0.0008-0.190 %) as compared to organisms of the order Selenomonadales, which were present in non-IBD controls at an average relative abundance of 1.02 % (range, 0.011-3.4 %). These same organisms were not detected at the disease margin or at the centre of the disease lesion in Crohn's disease.
The presence and increase in organisms of the Comamonadaceae and Xanthomonadaceae families within the submucosa at the resection margin may suggest early mucosal breakdown and bacterial translocation, which might be indicative of early disease onset (new inflammation). The emergence of unclassified Desulfovibrionales and the loss of unclassified Selenomonadales may be unique to the dysbiosis in Crohn's disease.
Differential changes in the mucosal microbiota at the different disease sites Although there were significant differences in the mucosal microbiota at different sites as compared to non-IBD controls Fig. 2 . Increased abundance of bacteria within submucosal tissues at the resection margin in patients with advanced Crohn's disease. Relative abundance of bacteria within submucosal tissues in relation to those detected within the submucosa of non-IBD controls. Bacteria of the order Desulfovibrionales were only detected in Crohn's disease cases and bacteria of the order Selenomonadales were only detected in non-IBD controls. (Fig. 1a, b) , there was no statistically significant difference in the relative abundance of bacteria between the three diseased sites examined in the present study. The lack of significant differences between the disease sites may have been largely due to gradual transitions between the areas examined (disease centre to disease margin to resection margin). The only observation was the decrease in organisms of the order Xanthomonadales and the family Xanthomonadaceae at the disease margin as compared to the disease centre (P=0.026). There was no significant difference between the disease margin and the resection margin.
Differences were observed when comparing the disease centre to the site of anastomoses (resection margin), which would be comparable to reports comparing the diseased and normal tissues in Crohn's disease cases [16] . In this comparison, diseased versus alleged healthy mucosal tissue, bacteria of the family Bifidobacteriaceae increased 3.7-fold in the normal mucosal tissue in relation to the diseased tissue (NM>DM; P=0.044), while bacteria of the family Xanthomonadaceae increased 11-fold in the diseased mucosal tissue as compared to the normal mucosa (DM>NM; P=0.012). The relative abundance of the corresponding orders of these bacteria was elevated similarly.
Bacteria of the unclassified family of the order Desulfovibrionales were present within the mucosal tissues of all sections, with both increasing frequency and abundance from the resection margin to the disease centre (Fig. 3) . These bacteria were present in 29 % (0.018 % relative abundance), in 67 % (0.033 % relative abundance) and in 70 % (0.037 % relative abundance) at the resection margin, disease margin and centre of the disease, respectively.
No difference in biodiversity or in bacterial richness was observed when we compared the mucosal microbial populations of the diseased centre, the disease margin and the resection margin.
Differential changes in the submucosal microbiota at different disease sites Although major changes were observed at each disease site when we compared the relative abundance in the superjacent mucosa and the subjacent submucosa, as with the mucosal microbiota, little difference was observed when we compared the submucosal bacterial abundance of the different disease sites. There was no significant difference between the disease centre and the advancing disease margin or between the disease centre and the resection margin. Differences were noted, however, between the disease margin and the resection margin, with organisms of the phylum Synergistetes being increased at the disease margin as compared to the anastomotic site (P=0.036). This reduced relative abundance was also present at the class and order levels (P=0.04). Bacteria of the order Enterorhabdus (phylum Actinobacteria) were also increased at the disease margin as compared to the anastomotic site (P=0.008).
Despite the lack of significant differences in the relative abundance of submucosal bacterial populations when comparing the three disease sites to each other, there were significant differences within the submucosa as compared to the superjacent mucosa (Fig. 4) . The advancing disease margin had the greatest number of increased bacteria (13 families) within the submucosal tissues as compared to the disease centre (4 families) and the resection margin (2 families), as well as the largest overall fold increase ( Table 1) .
Bacteria of the unclassified family of the order Desulfovibrionales, which were completely absent in non-IBD controls, in addition to being present on the mucosal surface, were also detected within the submucosal tissues of all Fig. 3 . Frequency (number of patients detected) and relative abundance of an unclassified family of the order Desulfovibrionales detected within mucosal (a) and submucosal (b) tissues of patients with Crohn's disease. These organisms increased in terms of both the number of patients in which the organism was detected and the relative abundance from the resection margin (anastomotic site) to the disease centre, including a spike within the submucosal tissues at the advancing disease margin.
sections, and showed increasing prevalence from the resection margin to the disease centre, increasing from 28 % at the resection margin to 45 % at the disease centre (Fig. 3) . The relative abundance, however, did not display a similar pattern, but rather peaked at the disease margin (0.021 %), with reduced abundance at both the disease centre (0.013 %) and the anastomotic site (0.011 %).
The anastomotic site (resection margin) tended to have the lowest number of bacteria within the submucosa as compared to the disease margin and the centre of the disease, corroborating the surgeon's gross evaluation as normal-appearing tissue. However, the presence of bacteria within the submucosa, which is suggestive of bacterial translocation, implies early inflammation and disease recurrence.
DISCUSSION
A major concern when dealing with tissues containing low bacterial biomass is possible contamination from exogenous as well as endogenous sources [14] . This concern is compounded with the challenges in separating the mucosa and submucosa without cross-contamination. Our data suggest that contamination was not a major contributing factor. If the submucosa is free of bacterial DNA and becomes contaminated with bacteria from the mucosa, the relative abundance of such a contamination will be equal to that of the mucosa. Since superjacent to subjacent samples from the same tissue and site were analysed, the relative abundance from cross-contamination would cancel out, i.e. the relative abundance would be the same in both mucosa and submucosa. Likewise, contamination from exogenous sources such as DNA extraction kits and sequencing reagents would be equal in both the mucosa and the submucosa, as they were extracted and processed on the same day with the same reagents [14] . Thus, the lack of any significant difference in relative abundance within the control non-IBD group suggests a lack of translocation. In Crohn's disease patients there was increased abundance of certain bacterial taxa as compared to the superjacent mucosa. This increased Fig. 4 . Changes in bacterial families within the submucosal tissues from the disease centre to the resection margin (anastomotic site). Fold increase/decrease in the abundance of bacterial families within submucosal tissues of the different diseased regions of the gastrointestinal tract. All organisms were significantly elevated and/or reduced within the submucosal tissues in relation to the superjacent mucosa in at least one diseased section examined. The amount of bacterial DNA reflected by the increase between the subjacent submucosa and the superjacent mucosa tissues supports the notion that bacterial translocation occurs primarily at the disease margin and that early translocation occurs at the resection margin.
bacterial abundance could only occur if an initial bacterial population (DNA) existed within the submucosa. Thus we believe that the increased abundance of certain bacterial types within the submucosa is real and cannot be attributed to mucosal or other contamination.
We examined three sections of the diseased intestinal tract in Crohn's disease patients in an attempt to obtain a full disease spectrum from within the same patient. The centre of the disease was chosen as the tissues most commonly examined in Crohn's disease representing advanced disease. Since some granulomatous diseases only have detectable quantities of aetiological agent at the advancing disease margin [17] , the advancing disease margin in Crohn's disease was examined as representing progressive disease. Lastly, since recurrence following intestinal resection generally occurs as new onset inflammation at the resection margin [18] , those patients having normal-appearing tissues at that site were examined as representing early disease. The determination of the microbiota at these disease sites within the same patient has not been conducted previously and demonstrates the importance of tissue selection in determining microbial compositions and their relevance to disease.
The degree of submucosal invasion by luminal bacteria was shown to differ between disease sites and was found to be most severe at the advancing disease margin, with the infiltration of 13 different bacterial families as opposed to 2 at the resection margin and 4 at the disease centre. These data support our earlier suggestions that this section of the disease, the advancing disease margin, is the predominant site of bacterial translocation across the mucosal barrier [5] .
The variety of organisms detected within the submucosal tissues, representing a total of 15 different bacterial families over the sites examined, suggests a generalized translocation of commensal bacteria rather than any specific organism(s) capable of transgressing the intestinal barrier and colonization of interstitial tissues. The multiplicity of bacteria found within submucosal tissues, and the failure to detect the same in the non-IBD controls, suggests that there is likely an underlying cause of the intestinal permeability and that the bacterial translocation is secondary to a primary event leading to a breakdown of the mucosal barrier.
Because we compared the microbiota in Crohn's disease to other intestinal diseases also known to be dysbiotic as opposed to normal, our data differ, with several features of the microbiota in Crohn's disease often considered to be unique. Previous studies have shown that there is reduced bacterial biodiversity and richness in Crohn's disease patients, which is attributed predominantly to the reduction in bacteria of the phylum Firmicutes [19] , including decreased abundance of Faecalibacterium prausnitzii [20] . In addition, both the faecal and mucosal microbiota in Crohn's disease patients are said to have increased abundance of Proteobacteria, which is associated with increased Enterobacteriaceae and Escherichia coli [19] . In contrast, we found that Proteobacteria were actually reduced in Crohn's disease as compared to other intestinal disease, and there was no increased abundance of Enterobacteriaceae or E. coli in comparison to the non-IBD group. Furthermore, no bacteria within the family Enterobacteriaceae showed a predilection for tissue invasion (increased abundance within submucosal tissues). We also found no decreased diversity within any phyla and increased richness in bacteria of the phyla Proteobacteia and Actinobacteria in Crohn's disease patients in comparison to our non-IBD control group. These data likely result from our comparison of the microbiota in Crohn's disease patients to the microbiota in patients with other intestinal diseases, as opposed to the microbiota in normal patients. Other factors that may have influenced these discrepancies include the depth of coverage of our sequencing methods. Most previous studies used sequencing depths of 10 000-30 000 [16, 21] , while our sequencing depth averaged 86 000 sequences per sample. Thus the lack of diversity and richness detected in other An unexpected finding was the detection of entire bacterial taxa that were either present solely or completely excluded in Crohn's disease patients. The role of these organisms of the order Desulfovibrionales, found only in Crohn's disease patients, and of the order Selenomonadales, present in non-IBD controls and absent in Crohn's disease patients, is unclear. Since these organisms could not be further classified into their respective families and were classified into their taxonomic order based on 85-89 % homology, identification cannot be certain. Organisms of the order Selenomonadales, unlike other Firmicutes, are Gram-negative bacterial strains related to the Clostridia; they may have been mistakenly separated from that group [22] . They are generally associated with the root canals of healthy human teeth and the gastrointestinal tract of ruminants. Why these organisms would be depleted in Crohn's disease patients is unknown.
Organisms of the order Desulfovibrionales are a poorly understood group of organisms that are Gram-negative anaerobes belonging to the phylum Proteobacteria. Despite the uncertainty regarding identification, this organism may be related to Bilophila wadsworthia [23] , an organism within the family Desulfovibrionaceae, order Desulfovibrionales. Bilophila wadsworthia, although a frequent anaerobic isolate from human colon, is a pathobiont associated with perforated and gangrenous appendicitis and may contain both adherence and endotoxin properties. This organism has also been shown to produce colitis in susceptible IL-10 knockout mice [24] . The emergence of this unclassified Desulfovibrionales and the depletion of an unclassified Selenomonadales may simply reflect environmental pressures created by the unique microenvironment of the diseased intestinal tissues in Crohn's disease patients or they may be related, directly or indirectly, to the disease aetiology. These organisms may be applicable to the development of disease biomarkers that can predict disease onset and/or a shifting intestinal microbiota that may predispose to disease.
The degree of bacterial translocation suggested by increased bacteria present within submucosal tissues across the spectrum of examined tissue sites suggests that the resection margin represents the site of new disease onset or early quiescent disease (smouldering embers), while the advancing disease margin is the primary site of bacterial translocation and active disease (burning edge), and the centre of the disease is where fibrotic tissue occupies much of the lesion (scorched earth). Such a comparison is consistent with the observations made herein and in our previous studies [4, 5] and may provide some insight into possible aetiopathogenic mechanisms. Since the disease is, as yet, incurable and will return in nearly 100 % of patients following resection [16, 25] , the argument that advanced disease is an inappropriate model of disease to study causation due to chemotherapeutic interventions over many, many years may not be valid. Although chemotherapeutic agents may alter the appearance of the disease, the causative factor(s) of the disease remains.
Our findings at the centre of the disease, the advancing disease margin and the resection margin in advanced Crohn's disease of the terminal ileum suggest that the examination of these tissues from the same patient and their comparison to tissues from patients with other dysbiotic intestinal diseases may provide a unique insight into the aetiopathogenesis of Crohn's disease.
